Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's total debt is โน1.157 Trillion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | โน1.153 T | -1.8% |
2023-12-31 | โน1.174 T | -17.47% |
2022-12-31 | โน1.423 T | 4.45% |
2021-12-31 | โน1.362 T | 173.88% |
2020-12-31 | โน497.60 B | 17.06% |
2019-12-31 | โน425.08 B | 74.44% |
2018-12-31 | โน243.67 B | 8.67% |
2017-12-31 | โน224.24 B | 18.62% |
2016-12-31 | โน189.05 B | -56.28% |
2015-12-31 | โน432.42 B | -24.43% |
2014-12-31 | โน572.23 B | 1.05% |
2013-12-31 | โน566.27 B | 74.41% |
2012-12-31 | โน324.68 B | 18.15% |
2011-12-31 | โน274.81 B | 39.8% |
2010-12-31 | โน196.58 B | 2.06% |
2009-12-31 | โน192.60 B | 6.69% |
2008-12-31 | โน180.53 B | 48.92% |
2007-12-31 | โน121.22 B | -2.28% |
2006-12-31 | โน124.05 B | -17.41% |
2005-12-31 | โน150.21 B | -19.23% |
2004-12-31 | โน185.96 B | -10.7% |
2003-12-31 | โน208.25 B | -6.55% |
2002-12-31 | โน222.84 B | 71.88% |
2001-12-31 | โน129.65 B | 17.71% |
2000-12-31 | โน110.14 B | -11.29% |
1999-12-31 | โน124.15 B | -13.28% |
1998-12-31 | โน143.16 B | 31.09% |
1997-12-31 | โน109.21 B | 48.85% |
1996-12-31 | โน73.37 B |